News

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network

EMERYVILLE, CA and BOULDER, CO / ACCESSWIRE / January 9, 2024 / NovaBay Pharmaceuticals, Inc. (NYSE American:NBY) and Sonoma Pharmaceuticals,…

2 years ago

Rancho Biosciences Welcomes Seventh Member to Single-Cell Data Science Consortium

SAN DIEGO, CA / ACCESSWIRE / January 9, 2024 / Rancho Biosciences, the leading Data Science Services company headquartered in…

2 years ago

Mazree and Capstone Health Alliance Join Forces to Revolutionize Equipment Value Recovery in Healthcare

Mazree, a cutting-edge provider of medical equipment disposition services, has announced a strategic partnership with Capstone Health Alliance, one of…

2 years ago

CardioComm Solutions Appoints New CFO

Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical…

2 years ago

Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft…

2 years ago

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to…

2 years ago

Sonendo Continues Expanding the Reach of Its GentleWave Procedure; Partners with Dental Purchasing Group

More Clinicians and Patients Will Now Have Access to This Revolutionary Technology for Less Invasive, Patient-Friendly Root Canal TherapyLAGUNA HILLS,…

2 years ago

Endologix Announces that Scott Ward Joins Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--#endologix--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment…

2 years ago

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…

2 years ago

Liviniti Announces Noom GLP-1 Companion and Comprehensive Weight Management Solution

Liviniti adopts Noom to support sustainable weight loss and healthier outcomes.Natchitoches, Louisiana--(Newsfile Corp. - January 9, 2024) - Liviniti, a…

2 years ago